ACTR-26. TOXICITY AND EFFICACY OF LOMUSTINE PLUS BEVACIZUMAB IN RECURRENT GLIOBLASTOMA PATIENTS

BACKGROUND: Bevacizumab combined with chemotherapy has shown high response rates in recurrent glioblastoma patients and responding patients have improved survival and quality of life. The Danish treatment recommendations for recurrent glioblastoma patients were recently changed by replacing irinotec...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Neuro Oncol
Главные авторы: Jakobsen, Jan Nyrop, Urup, Thomas, Grunnet, Kirsten, Christensen, Ib Jarle, Villingshøj, Mette, Poulsen, Hans Skovgaard
Формат: Artigo
Язык:Inglês
Опубликовано: Oxford University Press 2017
Предметы:
Abstracts
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692348/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.021
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы